129 related articles for article (PubMed ID: 27365266)
1. Triolimus: A Multi-Drug Loaded Polymeric Micelle Containing Paclitaxel, 17-AAG, and Rapamycin as a Novel Radiosensitizer.
Tomoda K; Tam YT; Cho H; Buehler D; Kozak KR; Kwon GS
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27365266
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG.
Hasenstein JR; Shin HC; Kasmerchak K; Buehler D; Kwon GS; Kozak KR
Mol Cancer Ther; 2012 Oct; 11(10):2233-42. PubMed ID: 22896668
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin.
Shin HC; Cho H; Lai TC; Kozak KR; Kolesar JM; Kwon GS
J Control Release; 2012 Oct; 163(1):93-9. PubMed ID: 22549011
[TBL] [Abstract][Full Text] [Related]
4. Protein Complexation and pH Dependent Release Using Boronic Acid Containing PEG-Polypeptide Copolymers.
Negri GE; Deming TJ
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27282493
[TBL] [Abstract][Full Text] [Related]
5. Epothilone B-based 3-in-1 polymeric micelle for anticancer drug therapy.
Shin DH; Kwon GS
Int J Pharm; 2017 Feb; 518(1-2):307-311. PubMed ID: 28062368
[TBL] [Abstract][Full Text] [Related]
6. The effect of 17-allylamino-17-demethoxygeldanamycin alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.
Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ
Endocrine; 2015 Apr; 48(3):886-93. PubMed ID: 25096912
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
Mishra GP; Nguyen D; Alani AW
Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of paclitaxel and tanespimycin in lipid nanoparticles enhanced anti-gastric-tumor effect in vitro and in vivo.
Ma L; Yang D; Li Z; Zhang X; Pu L
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):904-911. PubMed ID: 29757014
[TBL] [Abstract][Full Text] [Related]
9. Electron paramagnetic resonance highlights that the oxygen effect contributes to the radiosensitizing effect of paclitaxel.
Danhier F; Danhier P; Magotteaux N; De Preter G; Ucakar B; Karroum O; Jordan B; Gallez B; Préat V
PLoS One; 2012; 7(7):e40772. PubMed ID: 22808261
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of 17-AAG combined with paclitaxel on proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro].
Chen S; Chen X; Li Y; Yang S; Mo X; Zhang F; Mo K; Ding Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jun; 35(6):844-7. PubMed ID: 26111682
[TBL] [Abstract][Full Text] [Related]
11. Multidrug PLA-PEG filomicelles for concurrent delivery of anticancer drugs-The influence of drug-drug and drug-polymer interactions on drug loading and release properties.
Jelonek K; Li S; Kaczmarczyk B; Marcinkowski A; Orchel A; Musiał-Kulik M; Kasperczyk J
Int J Pharm; 2016 Aug; 510(1):365-74. PubMed ID: 27346726
[TBL] [Abstract][Full Text] [Related]
12. Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma.
Francis LK; Alsayed Y; Leleu X; Jia X; Singha UK; Anderson J; Timm M; Ngo H; Lu G; Huston A; Ehrlich LA; Dimmock E; Lentzsch S; Hideshima T; Roodman GD; Anderson KC; Ghobrial IM
Clin Cancer Res; 2006 Nov; 12(22):6826-35. PubMed ID: 17121904
[TBL] [Abstract][Full Text] [Related]
13. A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs.
Shin HC; Alani AW; Cho H; Bae Y; Kolesar JM; Kwon GS
Mol Pharm; 2011 Aug; 8(4):1257-65. PubMed ID: 21630670
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.
Moradi Z; Mohammadian M; Saberi H; Ebrahimifar M; Mohammadi Z; Ebrahimpour M; Behrouzkia Z
Daru; 2019 Jun; 27(1):111-119. PubMed ID: 30835081
[TBL] [Abstract][Full Text] [Related]
15. Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells.
Roforth MM; Tan C
Anticancer Drugs; 2008 Aug; 19(7):681-8. PubMed ID: 18594209
[TBL] [Abstract][Full Text] [Related]
16. The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition.
Enomoto A; Fukasawa T; Takamatsu N; Ito M; Morita A; Hosoi Y; Miyagawa K
Eur J Cancer; 2013 Nov; 49(16):3547-58. PubMed ID: 23886587
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with silver graphene quantum dot, radiation, and 17-AAG induces anticancer effects in breast cancer cells.
Esgandari K; Mohammadian M; Zohdiaghdam R; Rastin SJ; Alidadi S; Behrouzkia Z
J Cell Physiol; 2021 Apr; 236(4):2817-2828. PubMed ID: 32901933
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
19. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
[TBL] [Abstract][Full Text] [Related]
20. 17-Allylamino-17-Demethoxygeldanamycin and the Enhancement of PS-341-Induced Lung Cancer Cell Death by Blocking the NF-κB and PI3K/Akt Pathways.
Lee KH; Jang AH; Yoo CG
Am J Respir Cell Mol Biol; 2015 Sep; 53(3):412-21. PubMed ID: 25633180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]